Related content

Response to “Standardized methods must be used to compare the properties of botulinum toxin serotypes”

By  

MICROBIOLOGY AND IMMUNOLOGY, Vol. 61, Iss. 12, 2017-12 ,pp. : 560-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging Opportunities for Serotypes of Botulinum Neurotoxins

By Peng Chen Zhongxing   Morris J. Glenn   Rodriguez Ramon L.   Shukla Aparna Wagle   Tapia-Núñez John   Okun Michael S.  

Toxins, Vol. 4, Iss. 11, 2012-11 ,pp. : 1196-1222

MDPI

Access to resources Recommend Favorite

Botulinum Toxin A for Controlling Obesity

By Pero Raffaela   Coretti Lorena   Lembo Francesca  

Toxins, Vol. 8, Iss. 10, 2016-09 ,pp. : 281-281

MDPI

Access to resources Recommend Favorite

Botulinum toxin A for the Treatment of Overactive Bladder

By Hsieh Po-Fan   Chiu Hung-Chieh   Chen Kuan-Chieh   Chang Chao-Hsiang   Chou Eric Chieh-Lung  

Toxins, Vol. 8, Iss. 3, 2016-02 ,pp. : 59-59

MDPI

Access to resources Recommend Favorite

Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes

By Sharma Shashi K.   Basavanna Uma   Shukla Hem D.  

Toxins, Vol. 2, Iss. 1, 2009-12 ,pp. : 1-9

MDPI

Access to resources Recommend Favorite